Development and Clinical Evaluation of a CRISPR-Based Diagnostic for Rapid Group B Streptococcus Screening

Development and Clinical Evaluation of a CRISPR-Based Diagnostic for Rapid Group B Streptococcus Screening

Vertical transmission of group B Streptococcus (GBS) is among the leading causes of neonatal illness and death. Colonization with GBS usually is screened weeks before delivery during pregnancy, on the basis of which preventive measures, such as antibiotic prophylaxis, were taken. However, the accur...

Full description

Bibliographic Details
Main Authors: Lingxiao Jiang, Weiqi Zeng, Wanting Wu, Yingying Deng, Fusheng He, Wenli Liang, Mingyao Huang, Hong Huang, Yongjun Li, Xiaorui Wang, Hang Su, Shilei Pan, Teng Xu
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-09-01
Series:Emerging Infectious Diseases
Subjects:
group B Streptococcus
CRISPR
rapid diagnostic
screening
bacteria
streptococci
Online Access:https://wwwnc.cdc.gov/eid/article/27/9/20-0091_article

Internet

https://wwwnc.cdc.gov/eid/article/27/9/20-0091_article

Similar Items